worapt
Celsius Holdings (NASDAQ: CELH) fell sharply on Tuesday, a move that some analysts thought was overdone. Nielsen retail access data shows Celsius (CELH) year-over-year sales growth slowed, and selling pressure increased on the day For the one- and two-week tracking periods ending May 18, Celsius’ sales percentage (hepatocellular carcinoma)’s promotional prices continued to increase, and the company continued to lose a small portion of its market share.
Wedbush Securities analyst Gerald Pascarelli cautioned investors that Celsius (CELH) shares are more likely to experience an outsized reaction to Nielsen data than large beverage multinationals due to its higher proportion of sales in the United States. He also emphasized that as a less mature company, Celsius (CELH)’s valuation mainly depends on revenue trends and market share growth, rather than profits. He told Bloomberg: “Some of the recent data don’t look as good as people hoped, but I think double-digit gains are coming any time. I would classify it as an overreaction.” On the other hand, Stephens analysis Celsius (CELH) stock’s sudden plunge should be viewed as a buying opportunity, according to analyst Jim Salera.
Meanwhile, Morgan Stanley warned that tough comparisons will continue to be made in the coming quarters as energy drink maker Celsius Holdings’ (CELH) distribution and velocity growth continues to cycle since the start of its PepsiCo (PEP) distribution deal. Separately, Stifel recently said that more distribution changes at PepsiCo ( PEP ), including inventory reductions, could create some near-term headwinds for Celsius Holdings ( CELH ).
Celsius Holdings (CELH) shares fell 12.44% It rose to $83.15 after changing hands at $77.11 earlier in the session. CELH’s trading volume for the day exceeded 15 million shares. CELH’s 52-week trading range is $40.87 to $99.62. PepsiCo (PEP) Falls 3.27% Later in the afternoon.
